Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124305) titled 'A multicentre, randomised, double-blind, positive-control clinical trial evaluating dihydroartemisinin tablets for the treatment of discoid lupus erythematosus' on May 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: China-Japan Friendship Hospital
Condition:
Discoid lupus erythematosus
Intervention:
Trial Group 1 (Dihydroartemisinin 40mg Group):Dihydroartemisinin 40mg, twice daily, oral
Trial Group 2 (Dihydroartemisinin 60mg Group):Dihydroartemisinin 60mg, twice daily, oral
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-05-10
Target Sample Size...